Ryan Specialty (RYAN) Financials

$70.16 +1.51 (+2.20%)

Closing price 03:59 PM Eastern

Extended Trading

$70.24 +0.08 (+0.11%)

As of 06:08 PM Eastern

Annual Income Statements for Ryan Specialty

This table shows Ryan Specialty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	95	61	61	66	68	64
Consolidated Net Income / (Loss)	230	194	163	57	71	63
Net Income / (Loss) Continuing Operations	230	194	163	57	71	63
Total Pre-Tax Income	273	238	179	62	79	68
Total Operating Income	428	359	290	187	159	101
Total Gross Profit	2,516	2,078	1,725	1,433	1,018	765
Total Revenue	2,516	2,078	1,725	1,433	1,018	765
Operating Revenue	2,516	2,078	1,725	1,433	1,018	765
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	2,088	1,718	1,436	1,246	860	664
Selling, General & Admin Expense	352	276	197	139	107	118
Depreciation Expense	9.79	9.04	5.69	4.81	3.93	4.80
Amortization Expense	158	107	104	108	64	48
Other Operating Expenses / (Income)	1,591	1,321	1,129	992	686	494
Other Special Charges / (Income)	-23	5.42	0.44	2.89	-1.30	-1.60
Total Other Income / (Expense), net	-155	-121	-110	-125	-79	-33
Interest & Investment Income	-140	-111	-105	-0.76	0.44	-0.98
Other Income / (Expense), net	-15	-10	-5.07	-45	-32	3.47
Income Tax Expense	43	43	16	4.93	8.95	4.93
Net Income / (Loss) Attributable to Noncontrolling Interest	135	133	102	-9.24	2.41	-1.11
Basic Earnings per Share	$0.78	$0.53	$0.57	($0.07)	$0.00	$0.00
Weighted Average Basic Shares Outstanding	120.78M	114.36M	108.62M	105.73M	0.00	0.00
Diluted Earnings per Share	$0.71	$0.52	$0.52	($0.07)	$0.00	$0.00
Weighted Average Diluted Shares Outstanding	132.89M	125.75M	265.75M	105.73M	0.00	0.00
Weighted Average Basic & Diluted Shares Outstanding	261.91M	520.45M	519.30M	105.73M	0.00	0.00
Cash Dividends to Common per Share	$0.04	-	-	-	-	-

This table shows Ryan Specialty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-28	14	18	47	17	23	-5.05	30	13	18	12
Consolidated Net Income / (Loss)	-4.39	43	29	118	41	59	16	84	36	46	29
Net Income / (Loss) Continuing Operations	-4.39	43	29	118	41	59	16	84	36	46	29
Total Pre-Tax Income	51	69	20	137	47	59	41	95	43	52	33
Total Operating Income	100	109	81	164	73	96	70	123	70	79	61
Total Gross Profit	690	664	605	695	552	533	502	585	458	435	412
Total Revenue	690	664	605	695	552	533	502	585	458	435	412
Operating Revenue	690	664	605	695	552	533	502	585	458	435	412
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	590	554	523	531	479	437	432	462	388	356	351
Selling, General & Admin Expense	106	105	89	83	76	74	69	82	52	57	49
Depreciation Expense	2.64	2.97	2.47	2.27	2.08	2.47	2.20	2.18	2.19	1.79	1.46
Amortization Expense	65	60	39	31	28	28	30	24	25	25	26
Other Operating Expenses / (Income)	430	410	393	414	374	332	329	352	308	271	274
Other Special Charges / (Income)	-14	-24	-0.37	1.24	-0.07	1.06	1.85	1.80	0.71	1.28	0.42
Total Other Income / (Expense), net	-49	-40	-62	-28	-26	-37	-29	-27	-27	-28	-29
Interest & Investment Income	-50	-104	-45	3.72	5.61	-85	-29	1.62	2.00	-105	0.14
Other Income / (Expense), net	0.38	3.53	-17	-0.23	-1.75	-10	-0.07	-0.11	0.14	1.76	0.07
Income Tax Expense	55	26	-8.96	19	6.43	0.67	25	12	6.30	5.86	3.41
Net Income / (Loss) Attributable to Noncontrolling Interest	23	29	11	71	24	36	21	54	23	28	18
Basic Earnings per Share	($0.22)	$0.11	$0.15	$0.38	$0.14	$0.18	($0.04)	$0.27	$0.12	$0.16	$0.11
Weighted Average Basic Shares Outstanding	125.42M	120.78M	121.92M	118.39M	117.81M	114.36M	115.87M	112.92M	111.03M	108.62M	109.43M
Diluted Earnings per Share	($0.22)	$0.12	$0.09	$0.37	$0.13	$0.19	($0.04)	$0.26	$0.11	$0.15	$0.09
Weighted Average Diluted Shares Outstanding	125.42M	132.89M	272.69M	271.22M	269.92M	125.75M	115.87M	123.85M	266.98M	265.75M	266.35M
Weighted Average Basic & Diluted Shares Outstanding	262.43M	261.91M	261.84M	522.90M	520.89M	520.45M	520.50M	520.43M	519.56M	519.30M	519.21M
Cash Dividends to Common per Share	$0.05	-	$0.04	$0.04	$0.04	-	-	-	-	-	-

This table details how cash moves in and out of Ryan Specialty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	-76	-11	628	244	492	237
Net Cash From Operating Activities	515	477	336	273	135	150
Net Cash From Continuing Operating Activities	515	477	336	273	135	165
Net Income / (Loss) Continuing Operations	230	194	163	57	71	63
Consolidated Net Income / (Loss)	230	194	163	57	71	63
Depreciation Expense	9.79	9.04	5.69	4.81	3.93	4.80
Amortization Expense	189	126	120	119	69	50
Non-Cash Adjustments To Reconcile Net Income	99	103	112	123	34	28
Changes in Operating Assets and Liabilities, net	-13	45	-66	-31	-41	20
Net Cash From Investing Activities	-1,756	-476	-22	-458	-769	-148
Net Cash From Continuing Investing Activities	-1,756	-476	-22	-458	-769	-148
Purchase of Property, Plant & Equipment	-47	-30	-23	-353	-18	-8.09
Acquisitions	-1,709	-447	0.00	-109	-718	-121
Other Investing Activities, net	0.00	0.23	0.34	3.89	-9.31	-8.51
Net Cash From Financing Activities	1,167	-13	315	429	1,125	62
Net Cash From Continuing Financing Activities	1,167	-13	315	429	1,125	220
Repayment of Debt	-1,284	-17	-19	-20	-983	-267
Payment of Dividends	-185	-72	-40	-	-	-
Issuance of Debt	2,545	0.00	394	0.00	1,956	421
Other Financing Activities, net	91	76	-20	44	152	66
Effect of Exchange Rate Changes	-1.51	0.58	-0.13	-	-	0.27

This table details how cash moves in and out of Ryan Specialty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-369	325	-388	123	-135	153	-350	479	-294	229	-140
Net Cash From Operating Activities	-143	260	101	271	-117	227	105	304	-159	185	-14
Net Cash From Continuing Operating Activities	-143	260	101	271	-117	227	105	304	-159	185	-14
Net Income / (Loss) Continuing Operations	-4.39	43	29	118	41	59	16	84	36	46	29
Consolidated Net Income / (Loss)	-4.39	43	29	118	41	59	16	84	36	46	29
Depreciation Expense	2.64	2.97	2.47	2.27	2.08	2.47	2.20	2.18	2.19	1.79	1.46
Amortization Expense	69	64	56	35	33	32	34	29	30	30	30
Non-Cash Adjustments To Reconcile Net Income	74	25	38	23	13	24	41	19	18	16	27
Changes in Operating Assets and Liabilities, net	-284	125	-25	92	-205	109	12	169	-246	91	-102
Net Cash From Investing Activities	-573	-469	-1,050	-229	-7.63	-94	-273	-4.42	-105	-11	-4.90
Net Cash From Continuing Investing Activities	-573	-469	-1,050	-229	-7.63	-94	-273	-4.42	-105	-11	-4.90
Purchase of Property, Plant & Equipment	-17	-17	-7.10	-15	-7.63	-14	-11	-2.57	-2.79	-11	-5.23
Acquisitions	-556	-452	-1,043	-214	0.00	-81	-262	-1.87	-102	-	-
Net Cash From Financing Activities	337	542	553	82	-10	19	-183	180	-30	54	-119
Net Cash From Continuing Financing Activities	335	542	553	82	-10	19	-183	180	-30	54	-119
Repayment of Debt	-156	-409	-867	-8.25	0.00	-4.13	-4.13	-4.13	-4.13	-4.16	-4.13
Payment of Dividends	-22	-36	-40	-63	-46	-19	-18	-34	-0.26	-7.21	-6.46
Issuance of Debt	574	992	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-61	-5.87	-93	154	35	43	-161	219	-25	66	-109
Effect of Exchange Rate Changes	10	-7.16	7.65	-1.35	-0.66	1.41	-0.17	-0.74	0.09	1.15	-1.63

This table presents Ryan Specialty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	9,650	7,247	6,384	5,459	4,529
Total Current Assets	4,789	4,336	3,894	3,011	2,493
Cash & Equivalents	540	839	993	387	313
Accounts Receivable	390	294	231	210	178
Prepaid Expenses	9.22	8.72	8.58	7.73	8.84
Other Current Assets	3,850	3,194	2,661	2,406	1,994
Plant, Property, & Equipment, net	50	42	31	15	17
Total Noncurrent Assets	4,811	2,869	2,458	2,432	2,019
Long-Term Investments	71	46	39	45	47
Goodwill	2,647	1,646	1,315	1,309	1,224
Intangible Assets	1,476	611	486	574	605
Noncurrent Deferred & Refundable Income Taxes	448	384	397	383	0.00
Other Noncurrent Operating Assets	169	182	222	121	142
Total Liabilities & Shareholders' Equity	9,650	7,247	6,384	5,459	4,529
Total Liabilities	8,552	6,268	5,566	4,864	4,219
Total Current Liabilities	4,549	3,744	3,134	2,918	2,482
Short-Term Debt	52	35	31	23	19
Accounts Payable	249	136	119	99	116
Accrued Expenses	486	420	350	386	350
Other Current Liabilities	3,762	3,153	2,634	2,409	1,998
Total Noncurrent Liabilities	4,003	2,523	2,432	1,946	1,736
Long-Term Debt	3,231	1,944	1,952	1,567	1,566
Noncurrent Deferred & Payable Income Tax Liabilities	476	359	295	273	0.58
Noncurrent Employee Benefit Liabilities	49	25	10	4.37	69
Other Noncurrent Operating Liabilities	246	196	174	102	100
Total Equity & Noncontrolling Interests	1,098	980	818	595	71
Total Preferred & Common Equity	628	560	478	344	70
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	628	560	478	344	70
Common Stock	507	442	418	349	67
Retained Earnings	123	114	54	-7.06	0.00
Accumulated Other Comprehensive Income / (Loss)	-1.80	3.08	6.04	1.71	2.70
Noncontrolling Interest	471	420	339	251	1.30

This table presents Ryan Specialty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	9,890	8,479	8,272	7,117	6,426	7,236	6,047	5,688
Total Current Assets	4,609	4,019	5,123	4,216	3,586	4,659	3,469	3,200
Cash & Equivalents	204	235	612	665	754	966	705	833
Accounts Receivable	432	335	384	299	239	301	235	187
Prepaid Expenses	9.25	8.31	8.05	8.15	9.58	8.00	8.35	7.78
Other Current Assets	3,964	3,441	4,118	3,244	2,584	3,384	2,521	2,171
Plant, Property, & Equipment, net	60	46	46	43	32	33	32	23
Total Noncurrent Assets	5,221	4,413	3,104	2,857	2,807	2,544	2,546	2,466
Long-Term Investments	72	62	59	56	45	44	41	39
Goodwill	3,024	2,341	1,815	1,647	1,582	1,379	1,379	1,314
Intangible Assets	1,653	1,353	673	592	592	494	515	501
Noncurrent Deferred & Refundable Income Taxes	309	486	379	383	383	415	402	399
Other Noncurrent Operating Assets	162	171	179	180	205	212	209	213
Total Liabilities & Shareholders' Equity	9,890	8,479	8,272	7,117	6,426	7,236	6,047	5,688
Total Liabilities	8,833	7,377	7,199	6,142	5,485	6,292	5,195	4,930
Total Current Liabilities	4,399	3,966	4,696	3,677	2,982	3,827	2,767	2,518
Short-Term Debt	36	33	33	39	36	31	22	29
Accounts Payable	197	206	172	231	115	96	74	82
Accrued Expenses	230	325	398	184	273	337	158	233
Current Deferred & Payable Income Tax Liabilities	24	23	22	22	17	-	-	-
Other Current Liabilities	3,911	3,379	4,071	3,201	2,541	3,364	2,512	2,174
Total Noncurrent Liabilities	4,434	3,411	2,503	2,464	2,503	2,464	2,429	2,413
Long-Term Debt	3,653	2,647	1,941	1,943	1,945	1,949	1,950	1,953
Noncurrent Deferred & Payable Income Tax Liabilities	462	454	345	339	342	310	288	295
Noncurrent Employee Benefit Liabilities	58	52	62	30	22	18	16	9.07
Other Noncurrent Operating Liabilities	262	259	156	153	193	187	174	155
Total Equity & Noncontrolling Interests	1,057	1,102	1,073	975	941	944	852	758
Total Preferred & Common Equity	543	633	606	554	543	559	509	443
Preferred Stock	0.00	0.00	0.00	0.00	0.00	-	-	-
Total Common Equity	543	633	606	554	543	559	509	443
Common Stock	459	501	478	460	443	453	437	402
Retained Earnings	79	125	122	89	92	97	67	36
Accumulated Other Comprehensive Income / (Loss)	4.47	7.08	5.90	6.10	8.24	8.53	4.28	4.37
Noncontrolling Interest	515	469	467	420	398	385	343	315

This table displays calculated financial ratios and metrics derived from Ryan Specialty's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	21.09%	20.42%	20.41%	40.71%	33.09%	0.00%
EBITDA Growth	26.39%	17.85%	54.45%	33.69%	24.89%	0.00%
EBIT Growth	18.37%	22.59%	100.76%	12.20%	20.82%	0.00%
NOPAT Growth	22.95%	11.28%	53.64%	22.03%	50.11%	0.00%
Net Income Growth	18.22%	19.13%	188.28%	-19.69%	11.82%	0.00%
EPS Growth	36.54%	0.00%	842.86%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	7.89%	42.23%	22.68%	102.00%	-9.44%	0.00%
Free Cash Flow Firm Growth	-11,620.62%	-104.61%	654.09%	96.80%	0.00%	0.00%
Invested Capital Growth	81.78%	17.24%	0.95%	14.08%	0.00%	0.00%
Revenue Q/Q Growth	5.48%	4.94%	3.38%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	10.65%	1.75%	40.37%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	6.96%	1.45%	69.12%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	-7.05%	8.79%	10.02%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-6.49%	7.00%	10.99%	0.00%	0.00%	0.00%
EPS Q/Q Growth	-8.97%	8.33%	13.04%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	6.80%	9.74%	24.22%	-4.87%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-37.25%	-172.86%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	8.22%	-2.29%	-5.32%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	24.30%	23.28%	23.79%	18.55%	19.52%	20.80%
Operating Margin	17.01%	17.28%	16.78%	13.03%	15.57%	13.21%
EBIT Margin	16.41%	16.78%	16.49%	9.89%	12.40%	13.66%
Profit (Net Income) Margin	9.14%	9.36%	9.46%	3.95%	6.92%	8.24%
Tax Burden Percent	84.36%	81.74%	91.11%	91.99%	88.73%	92.75%
Interest Burden Percent	66.03%	68.23%	63.00%	43.45%	62.93%	65.05%
Effective Tax Rate	15.65%	18.26%	8.89%	8.01%	11.27%	7.25%
Return on Invested Capital (ROIC)	12.35%	15.28%	14.98%	10.44%	18.32%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	5.40%	5.59%	5.45%	0.79%	6.86%	0.00%
Return on Net Nonoperating Assets (RNNOA)	9.78%	6.36%	8.13%	2.07%	27.07%	0.00%
Return on Equity (ROE)	22.13%	21.64%	23.11%	12.51%	45.39%	0.00%
Cash Return on Invested Capital (CROIC)	-45.70%	-0.59%	14.04%	-2.71%	-181.69%	0.00%
Operating Return on Assets (OROA)	4.89%	5.12%	4.80%	2.84%	2.79%	0.00%
Return on Assets (ROA)	2.72%	2.85%	2.76%	1.13%	1.56%	0.00%
Return on Common Equity (ROCE)	12.65%	12.50%	13.45%	5.71%	10.19%	0.00%
Return on Equity Simple (ROE_SIMPLE)	36.63%	34.74%	34.13%	16.47%	101.04%	0.00%
Net Operating Profit after Tax (NOPAT)	361	294	264	172	141	94
NOPAT Margin	14.35%	14.13%	15.29%	11.98%	13.82%	12.25%
Net Nonoperating Expense Percent (NNEP)	6.96%	9.68%	9.53%	9.65%	11.45%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	8.24%	9.92%	9.42%	-	-	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	13.99%	13.29%	11.42%	9.70%	10.55%	15.45%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	82.99%	82.72%	83.22%	86.97%	84.43%	86.79%
Earnings before Interest and Taxes (EBIT)	413	349	284	142	126	105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	611	484	410	266	199	159
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	26.77	39.54	44.53	60.21	19.17	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	6.68	10.65	12.35	14.45	1.31	1.75
Price to Earnings (P/E)	177.47	362.64	348.95	314.21	19.64	20.85
Dividend Yield	0.87%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.56%	0.28%	0.29%	0.32%	5.09%	4.80%
Enterprise Value to Invested Capital (EV/IC)	5.29	11.40	12.77	12.61	1.83	0.00
Enterprise Value to Revenue (EV/Rev)	7.93	11.38	13.10	15.43	2.75	0.00
Enterprise Value to EBITDA (EV/EBITDA)	32.62	48.89	55.05	83.19	14.11	0.00
Enterprise Value to EBIT (EV/EBIT)	48.31	67.82	79.44	156.03	22.21	0.00
Enterprise Value to NOPAT (EV/NOPAT)	55.26	80.57	85.66	128.77	19.93	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	38.73	49.56	67.34	80.83	20.71	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	91.40	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	2.99	2.02	2.42	2.67	5.10	0.00
Long-Term Debt to Equity	2.94	1.98	2.39	2.63	5.04	0.00
Financial Leverage	1.81	1.14	1.49	2.63	3.94	0.00
Leverage Ratio	8.13	7.58	8.38	11.03	14.58	0.00
Compound Leverage Factor	5.37	5.17	5.28	4.79	9.17	0.00
Debt to Total Capital	74.93%	66.89%	70.80%	72.78%	83.61%	0.00%
Short-Term Debt to Total Capital	1.18%	1.20%	1.09%	1.07%	1.01%	0.00%
Long-Term Debt to Total Capital	73.75%	65.70%	69.70%	71.70%	82.60%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	10.74%	14.19%	12.12%	11.49%	12.71%	0.00%
Common Equity to Total Capital	14.33%	18.92%	17.08%	15.73%	3.68%	0.00%
Debt to EBITDA	5.37	4.09	4.83	5.98	7.98	0.00
Net Debt to EBITDA	4.37	2.26	2.32	4.36	6.17	0.00
Long-Term Debt to EBITDA	5.29	4.02	4.76	5.90	7.88	0.00
Debt to NOPAT	9.10	6.74	7.52	9.26	11.27	0.00
Net Debt to NOPAT	7.40	3.73	3.61	6.74	8.71	0.00
Long-Term Debt to NOPAT	8.95	6.62	7.40	9.13	11.13	0.00
Altman Z-Score	1.63	2.68	2.87	2.92	0.51	0.00
Noncontrolling Interest Sharing Ratio	42.86%	42.24%	41.80%	54.33%	77.54%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.05	1.16	1.24	1.03	1.00	0.00
Quick Ratio	0.20	0.30	0.39	0.20	0.20	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,335	-11	247	-45	-1,396	0.00
Operating Cash Flow to CapEx	1,095.44%	1,602.64%	1,474.33%	77.49%	763.47%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-0.56	-29.54	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	3.45	2.87	4.21
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-1.00	2.49	4.34
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.30	0.30	0.29	0.29	0.22	0.00
Accounts Receivable Turnover	7.36	7.91	7.81	7.39	5.73	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	54.31	56.38	74.10	87.60	58.44	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	49.62	46.17	46.72	49.42	63.70	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	49.62	46.17	46.72	49.42	63.70	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	3,770	2,074	1,769	1,752	1,536	0.00
Invested Capital Turnover	0.86	1.08	0.98	0.87	1.33	0.00
Increase / (Decrease) in Invested Capital	1,696	305	17	216	1,536	0.00
Enterprise Value (EV)	19,942	23,648	22,595	22,106	2,804	0.00
Market Capitalization	16,800	22,134	21,304	20,698	1,338	1,338
Book Value per Share	$2.40	$1.08	$0.92	$0.66	$1.23	$0.00
Tangible Book Value per Share	($13.35)	($3.26)	($2.55)	($2.97)	($30.91)	$0.00
Total Capital	4,381	2,959	2,800	2,185	1,896	0.00
Total Debt	3,283	1,979	1,982	1,590	1,585	0.00
Total Long-Term Debt	3,231	1,944	1,952	1,567	1,566	0.00
Net Debt	2,672	1,094	951	1,158	1,225	0.00
Capital Expenditures (CapEx)	47	30	23	353	18	-4.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-249	-212	-202	-271	-282	0.00
Debt-free Net Working Capital (DFNWC)	292	627	790	116	30	0.00
Net Working Capital (NWC)	240	591	760	93	11	0.00
Net Nonoperating Expense (NNE)	131	99	101	115	70	31
Net Nonoperating Obligations (NNO)	2,672	1,094	951	1,158	1,225	0.00
Total Depreciation and Amortization (D&A)	199	135	126	124	73	55
Debt-free, Cash-free Net Working Capital to Revenue	-9.89%	-10.21%	-11.73%	-18.89%	-27.74%	0.00%
Debt-free Net Working Capital to Revenue	11.59%	30.16%	45.81%	8.12%	2.96%	0.00%
Net Working Capital to Revenue	9.53%	28.46%	44.04%	6.48%	1.08%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.78	$0.53	$0.57	($0.07)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	120.78M	114.36M	108.62M	259.06M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.71	$0.52	$0.52	($0.07)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	132.89M	125.75M	265.75M	259.06M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.07)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	261.91M	520.45M	519.30M	105.73M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	342	298	264	174	140	92
Normalized NOPAT Margin	13.58%	14.34%	15.31%	12.17%	13.70%	12.06%
Pre Tax Income Margin	10.83%	11.45%	10.39%	4.30%	7.80%	8.89%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	1.79	2.67	2.94
NOPAT to Interest Expense	0.00	0.00	0.00	2.16	2.98	2.64
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-2.66	2.30	3.08
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-2.28	2.60	2.77
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	80.53%	36.85%	24.43%	0.00%	0.00%	0.00%
Augmented Payout Ratio	80.53%	36.85%	24.43%	462.41%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Ryan Specialty's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	25.02%	24.52%	20.47%	18.85%	20.64%	22.49%	21.83%	19.10%	18.28%	14.92%	16.79%
EBITDA Growth	62.42%	48.68%	16.34%	30.94%	3.65%	7.38%	13.93%	11.68%	53.83%	2,173.03%	96.69%
EBIT Growth	41.91%	31.23%	-6.97%	33.73%	0.96%	6.16%	13.58%	15.62%	95.79%	329.84%	296.68%
NOPAT Growth	-113.74%	-29.25%	338.37%	31.57%	4.97%	35.56%	-50.77%	18.48%	3.43%	51.78%	10,852.08%
Net Income Growth	-110.79%	-27.26%	82.40%	40.83%	11.58%	27.79%	-46.37%	19.53%	101.69%	54.59%	189.84%
EPS Growth	-269.23%	-36.84%	325.00%	42.31%	18.18%	26.67%	-144.44%	18.18%	83.33%	66.67%	156.25%
Operating Cash Flow Growth	-22.56%	14.45%	-4.32%	-10.93%	26.80%	22.94%	868.55%	32.09%	-143.18%	54.91%	-129.42%
Free Cash Flow Firm Growth	-2,286.38%	-676.82%	-447.08%	-1,070.13%	42.53%	-490.52%	-83.08%	88.02%	90.90%	0.00%	92.66%
Invested Capital Growth	99.99%	81.78%	64.12%	24.17%	7.54%	17.24%	13.60%	7.61%	12.04%	0.95%	10.59%
Revenue Q/Q Growth	4.01%	9.73%	-13.05%	25.98%	3.60%	6.16%	-14.22%	27.87%	5.19%	5.59%	-16.14%
EBITDA Q/Q Growth	-4.13%	45.36%	-38.69%	90.09%	-12.25%	13.75%	-30.99%	50.47%	-9.08%	20.68%	-32.36%
EBIT Q/Q Growth	-10.85%	73.92%	-60.47%	131.51%	-17.56%	23.29%	-43.17%	74.77%	-13.31%	31.91%	-42.15%
NOPAT Q/Q Growth	-112.79%	-43.18%	-16.43%	126.18%	-34.13%	252.09%	-74.92%	80.45%	-14.93%	27.87%	-39.64%
Net Income Q/Q Growth	-110.31%	48.57%	-75.73%	190.18%	-30.47%	272.56%	-81.27%	129.91%	-20.37%	56.36%	-58.24%
EPS Q/Q Growth	-283.33%	33.33%	-75.68%	184.62%	-31.58%	575.00%	-115.38%	136.36%	-26.67%	66.67%	-59.09%
Operating Cash Flow Q/Q Growth	-155.01%	157.22%	-62.73%	332.39%	-151.37%	115.04%	-65.30%	290.97%	-186.28%	1,444.29%	-105.96%
Free Cash Flow Firm Q/Q Growth	-37.76%	-31.08%	-287.64%	-240.92%	55.16%	7.68%	-729.09%	83.26%	-404.71%	143.28%	45.76%
Invested Capital Q/Q Growth	18.57%	8.22%	46.62%	6.30%	7.78%	-2.29%	10.93%	-7.94%	17.49%	-5.32%	5.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	24.97%	27.09%	20.45%	29.01%	19.22%	22.69%	21.18%	26.33%	22.37%	25.89%	22.65%
Operating Margin	14.52%	16.48%	13.47%	23.64%	13.16%	18.08%	13.91%	20.99%	15.32%	18.22%	14.89%
EBIT Margin	14.58%	17.01%	10.73%	23.60%	12.84%	16.14%	13.90%	20.97%	15.35%	18.62%	14.91%
Profit (Net Income) Margin	-0.64%	6.41%	4.74%	16.97%	7.37%	10.98%	3.13%	14.32%	7.97%	10.52%	7.11%
Tax Burden Percent	-8.60%	61.64%	145.54%	86.33%	86.36%	98.86%	38.74%	87.80%	85.28%	88.65%	89.57%
Interest Burden Percent	50.73%	61.18%	30.33%	83.30%	66.44%	68.81%	58.11%	77.78%	60.88%	63.75%	53.23%
Effective Tax Rate	108.60%	38.36%	-45.54%	13.67%	13.64%	1.14%	61.26%	12.20%	14.72%	11.35%	10.43%
Return on Invested Capital (ROIC)	-0.99%	8.74%	16.68%	21.71%	11.44%	19.32%	5.35%	18.87%	11.93%	15.82%	12.51%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.81%	7.42%	11.64%	19.61%	9.67%	15.73%	4.36%	16.52%	10.03%	13.50%	10.22%
Return on Net Nonoperating Assets (RNNOA)	-1.86%	13.46%	20.30%	22.09%	13.17%	17.90%	5.88%	20.55%	16.71%	20.16%	17.49%
Return on Equity (ROE)	-2.85%	22.20%	36.99%	43.81%	24.62%	37.23%	11.22%	39.41%	28.63%	35.98%	30.00%
Cash Return on Invested Capital (CROIC)	-57.58%	-45.70%	-34.70%	-6.12%	6.48%	-0.59%	0.78%	8.53%	2.66%	14.04%	0.00%
Operating Return on Assets (OROA)	4.55%	5.06%	3.43%	6.95%	4.24%	4.92%	4.54%	5.80%	4.78%	5.43%	4.72%
Return on Assets (ROA)	-0.20%	1.91%	1.52%	5.00%	2.43%	3.35%	1.02%	3.96%	2.48%	3.07%	2.25%
Return on Common Equity (ROCE)	-1.54%	12.69%	21.29%	25.30%	14.33%	21.50%	6.51%	23.19%	17.08%	20.94%	17.26%
Return on Equity Simple (ROE_SIMPLE)	34.07%	0.00%	38.85%	38.45%	35.84%	0.00%	33.47%	34.95%	35.71%	0.00%	33.22%
Net Operating Profit after Tax (NOPAT)	-8.62	67	119	142	63	95	27	108	60	70	55
NOPAT Margin	-1.25%	10.15%	19.61%	20.40%	11.36%	17.87%	5.39%	18.43%	13.06%	16.15%	13.34%
Net Nonoperating Expense Percent (NNEP)	-0.18%	1.32%	5.05%	2.10%	1.77%	3.59%	0.99%	2.35%	1.90%	2.32%	2.29%
Return On Investment Capital (ROIC_SIMPLE)	-0.18%	1.54%	-	-	-	3.22%	-	-	-	2.51%	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	15.37%	15.75%	14.67%	11.93%	13.74%	13.81%	13.80%	13.95%	11.30%	13.13%	11.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	85.48%	83.52%	86.53%	76.36%	86.84%	81.92%	86.09%	79.01%	84.68%	81.78%	85.11%
Earnings before Interest and Taxes (EBIT)	101	113	65	164	71	86	70	123	70	81	61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	172	180	124	202	106	121	106	154	102	113	93
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	35.66	26.77	54.86	49.71	51.92	39.54	45.93	41.31	40.68	44.53	47.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	7.29	6.68	14.56	13.19	13.25	10.65	12.60	12.22	11.52	12.35	12.51
Price to Earnings (P/E)	383.20	177.47	334.58	371.23	446.81	362.64	444.63	316.83	307.39	348.95	392.41
Dividend Yield	0.92%	0.87%	0.68%	0.59%	0.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.26%	0.56%	0.30%	0.27%	0.22%	0.28%	0.22%	0.32%	0.33%	0.29%	0.25%
Enterprise Value to Invested Capital (EV/IC)	5.21	5.29	10.78	13.42	13.63	11.40	12.49	12.77	10.71	12.77	11.94
Enterprise Value to Revenue (EV/Rev)	8.77	7.93	15.75	13.97	14.02	11.38	13.39	12.94	12.39	13.10	13.37
Enterprise Value to EBITDA (EV/EBITDA)	34.35	32.62	68.00	59.59	62.50	48.89	55.78	52.87	49.88	55.05	76.29
Enterprise Value to EBIT (EV/EBIT)	52.60	48.31	97.34	81.59	87.19	67.82	77.15	72.89	69.82	79.44	132.62
Enterprise Value to NOPAT (EV/NOPAT)	76.45	55.26	96.76	96.27	102.70	80.57	98.28	83.50	80.75	85.66	93.04
Enterprise Value to Operating Cash Flow (EV/OCF)	47.64	38.73	77.92	65.52	58.59	49.56	60.98	77.44	92.06	67.34	82.58
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	217.83	0.00	1,695.88	155.21	425.74	91.40	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	3.49	2.99	2.43	1.84	2.03	2.02	2.10	2.10	2.32	2.42	2.62
Long-Term Debt to Equity	3.45	2.94	2.40	1.81	1.99	1.98	2.07	2.06	2.29	2.39	2.58
Financial Leverage	2.30	1.81	1.74	1.13	1.36	1.14	1.35	1.24	1.67	1.49	1.71
Leverage Ratio	8.37	8.13	7.30	7.69	7.21	7.58	7.13	8.31	7.82	8.38	8.03
Compound Leverage Factor	4.25	4.97	2.21	6.40	4.79	5.22	4.14	6.47	4.76	5.34	4.28
Debt to Total Capital	77.72%	74.93%	70.87%	64.78%	67.03%	66.89%	67.79%	67.71%	69.85%	70.80%	72.35%
Short-Term Debt to Total Capital	0.76%	1.18%	0.88%	1.08%	1.33%	1.20%	1.22%	1.05%	0.80%	1.09%	1.06%
Long-Term Debt to Total Capital	76.96%	73.75%	69.99%	63.70%	65.70%	65.70%	66.57%	66.66%	69.05%	69.70%	71.29%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	10.85%	10.74%	12.39%	15.34%	14.22%	14.19%	13.63%	13.17%	12.14%	12.12%	11.49%
Common Equity to Total Capital	11.43%	14.33%	16.74%	19.88%	18.75%	18.92%	18.58%	19.12%	18.01%	17.08%	16.16%
Debt to EBITDA	5.44	5.37	4.85	3.69	4.07	4.09	4.17	4.28	4.42	4.83	6.78
Net Debt to EBITDA	5.04	4.37	4.31	2.43	2.59	2.26	2.49	2.10	2.75	2.32	3.80
Long-Term Debt to EBITDA	5.39	5.29	4.79	3.63	3.99	4.02	4.09	4.21	4.37	4.76	6.68
Debt to NOPAT	12.12	9.10	6.90	5.96	6.68	6.74	7.34	6.76	7.16	7.52	8.27
Net Debt to NOPAT	11.21	7.40	6.14	3.93	4.25	3.73	4.38	3.31	4.45	3.61	4.63
Long-Term Debt to NOPAT	12.00	8.95	6.82	5.86	6.55	6.62	7.21	6.66	7.08	7.40	8.15
Altman Z-Score	1.65	1.53	3.16	2.93	3.26	2.56	3.21	2.68	2.88	2.76	3.02
Noncontrolling Interest Sharing Ratio	46.02%	42.86%	42.44%	42.26%	41.80%	42.24%	41.97%	41.16%	40.33%	41.80%	42.45%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.05	1.05	1.01	1.09	1.15	1.16	1.20	1.22	1.25	1.24	1.27
Quick Ratio	0.14	0.20	0.14	0.21	0.26	0.30	0.33	0.33	0.34	0.39	0.41
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2,244	-1,629	-1,243	-321	-94	-210	-227	-27	-164	54	-124
Operating Cash Flow to CapEx	-821.12%	1,501.16%	1,421.69%	1,808.29%	-1,527.78%	1,648.39%	990.51%	11,835.23%	-5,700.36%	1,719.60%	-262.52%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-10.30	-3.20	0.00	0.00	-0.95	-5.55	0.00	-4.30
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	8.70	-3.96	0.00	0.00	10.53	-5.40	0.00	-0.48
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	8.22	-4.22	0.00	0.00	10.44	-5.50	0.00	-0.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.31	0.30	0.32	0.29	0.33	0.30	0.33	0.28	0.31	0.29	0.32
Accounts Receivable Turnover	7.25	7.36	8.32	6.66	8.14	7.91	9.29	6.92	8.47	7.81	9.29
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	51.50	54.31	61.22	58.47	58.31	56.38	72.15	77.80	77.27	74.10	88.52
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	50.31	49.62	43.88	54.81	44.85	46.17	39.28	52.71	43.11	46.72	39.27
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	50.31	49.62	43.88	54.81	44.85	46.17	39.28	52.71	43.11	46.72	39.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,470	3,770	3,484	2,376	2,235	2,074	2,123	1,914	2,078	1,769	1,868
Invested Capital Turnover	0.79	0.86	0.85	1.06	1.01	1.08	0.99	1.02	0.91	0.98	0.94
Increase / (Decrease) in Invested Capital	2,235	1,696	1,361	462	157	305	254	135	223	17	179
Enterprise Value (EV)	23,275	19,942	37,566	31,884	30,461	23,648	26,517	24,445	22,258	22,595	22,305
Market Capitalization	19,347	16,800	34,715	30,114	28,780	22,134	24,937	23,090	20,688	21,304	20,879
Book Value per Share	$2.07	$2.40	$1.21	$1.16	$4.71	$1.08	$1.04	$1.08	$0.98	$0.92	$0.85
Tangible Book Value per Share	($15.79)	($13.35)	($5.85)	($3.61)	($14.30)	($3.26)	($3.13)	($2.53)	($2.67)	($2.55)	($2.64)
Total Capital	4,746	4,381	3,781	3,047	2,957	2,959	2,922	2,923	2,824	2,800	2,740
Total Debt	3,689	3,283	2,680	1,974	1,982	1,979	1,981	1,979	1,973	1,982	1,983
Total Long-Term Debt	3,653	3,231	2,647	1,941	1,943	1,944	1,945	1,949	1,950	1,952	1,953
Net Debt	3,413	2,672	2,382	1,303	1,260	1,094	1,181	970	1,227	951	1,111
Capital Expenditures (CapEx)	17	17	7.10	15	7.63	14	11	2.57	2.79	11	5.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	43	-249	-148	-153	-87	-212	-114	-104	20	-202	-122
Debt-free Net Working Capital (DFNWC)	247	292	87	459	578	627	640	862	725	790	711
Net Working Capital (NWC)	211	240	53	426	539	591	605	832	702	760	682
Net Nonoperating Expense (NNE)	-4.23	25	90	24	22	37	11	24	23	24	26
Net Nonoperating Obligations (NNO)	3,413	2,672	2,382	1,303	1,260	1,094	1,181	970	1,227	951	1,111
Total Depreciation and Amortization (D&A)	72	67	59	38	35	35	37	31	32	32	32
Debt-free, Cash-free Net Working Capital to Revenue	1.63%	-9.89%	-6.22%	-6.71%	-4.01%	-10.21%	-5.77%	-5.48%	1.12%	-11.73%	-7.32%
Debt-free Net Working Capital to Revenue	9.30%	11.59%	3.64%	20.13%	26.63%	30.16%	32.34%	45.64%	40.36%	45.81%	42.60%
Net Working Capital to Revenue	7.93%	9.53%	2.24%	18.68%	24.82%	28.46%	30.54%	44.02%	39.11%	44.04%	40.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.22)	$0.11	$0.15	$0.38	$0.14	$0.18	($0.04)	$0.27	$0.12	$0.16	$0.11
Adjusted Weighted Average Basic Shares Outstanding	125.42M	120.78M	121.92M	118.39M	117.81M	114.36M	115.87M	112.92M	111.03M	108.62M	109.43M
Adjusted Diluted Earnings per Share	($0.22)	$0.12	$0.09	$0.37	$0.13	$0.19	($0.04)	$0.26	$0.11	$0.15	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	125.42M	132.89M	272.69M	271.22M	269.92M	125.75M	115.87M	123.85M	266.98M	265.75M	266.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	262.43M	261.91M	261.84M	522.90M	520.89M	520.45M	520.50M	520.43M	519.56M	519.30M	519.21M
Normalized Net Operating Profit after Tax (NOPAT)	60	53	57	143	63	96	50	109	60	71	55
Normalized NOPAT Margin	8.74%	7.96%	9.39%	20.56%	11.35%	18.07%	9.99%	18.70%	13.19%	16.41%	13.43%
Pre Tax Income Margin	7.40%	10.41%	3.25%	19.66%	8.53%	11.11%	8.07%	16.32%	9.34%	11.87%	7.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	5.27	2.41	0.00	0.00	4.25	2.38	0.00	2.13
NOPAT to Interest Expense	0.00	0.00	0.00	4.56	2.13	0.00	0.00	3.73	2.03	0.00	1.90
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	4.79	2.15	0.00	0.00	4.16	2.29	0.00	1.95
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	4.08	1.87	0.00	0.00	3.65	1.93	0.00	1.72
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	87.30%	80.53%	68.39%	62.69%	58.91%	36.85%	32.92%	24.67%	22.00%	24.43%	0.00%
Augmented Payout Ratio	87.30%	80.53%	68.39%	62.69%	58.91%	36.85%	32.92%	24.67%	22.00%	24.43%	0.00%

Frequently Asked Questions About Ryan Specialty's Financials

When does Ryan Specialty's financial year end?

According to the most recent income statement we have on file, Ryan Specialty's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ryan Specialty's net income changed over the last 5 years?

Ryan Specialty's net income appears to be on an upward trend, with a most recent value of $229.91 million in 2024, rising from $63.06 million in 2019. The previous period was $194.48 million in 2023. See where experts think Ryan Specialty is headed by visiting Ryan Specialty's forecast page.

What is Ryan Specialty's operating income?

Ryan Specialty's total operating income in 2024 was $427.81 million, based on the following breakdown:

Total Gross Profit: $2.52 billion
Total Operating Expenses: $2.09 billion

How has Ryan Specialty revenue changed over the last 5 years?

Over the last 5 years, Ryan Specialty's total revenue changed from $765.11 million in 2019 to $2.52 billion in 2024, a change of 228.8%.

How much debt does Ryan Specialty have?

Ryan Specialty's total liabilities were at $8.55 billion at the end of 2024, a 36.4% increase from 2023, and a 102.7% increase since 2020.

How much cash does Ryan Specialty have?

In the past 4 years, Ryan Specialty's cash and equivalents has ranged from $312.65 million in 2020 to $992.72 million in 2022, and is currently $540.20 million as of their latest financial filing in 2024.

How has Ryan Specialty's book value per share changed over the last 5 years?

Over the last 5 years, Ryan Specialty's book value per share changed from 0.00 in 2019 to 2.40 in 2024, a change of 239.7%.

Related Companies

This page (NYSE:RYAN) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryan Specialty (RYAN) Financials

Frequently Asked Questions About Ryan Specialty's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryan Specialty (RYAN) Financials

Annual Income Statements for Ryan Specialty

Quarterly Income Statements for Ryan Specialty

Annual Cash Flow Statements for Ryan Specialty

Quarterly Cash Flow Statements for Ryan Specialty

Annual Balance Sheets for Ryan Specialty

Quarterly Balance Sheets for Ryan Specialty

Annual Metrics And Ratios for Ryan Specialty

Quarterly Metrics And Ratios for Ryan Specialty

Frequently Asked Questions About Ryan Specialty's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools